Third-Line Treatment Options for Metastatic Colorectal Cancer - Episode 2

Nuances With Defining “Refractory” mCRC in the Third-Line Setting

November 21, 2024

Marwan G. Fakih, MD, City of Hope, Nilo Azad, MD

Panelists discuss how “refractory” metastatic colorectal cancer (mCRC) is defined in the third- vs fourth-line setting, and the treatment goals in the third-line setting, focusing on optimizing patient outcomes and managing progression after prior therapies.

EP. 1: Navigating mCRC: Treatment Options in the Third-Line Setting

Now Viewing

EP. 2: Nuances With Defining “Refractory” mCRC in the Third-Line Setting

How do you define “refractory” mCRC in the third- vs fourth-line setting, and what are your treatment goals in the third-line setting?